Böhm E, Fabel H
Abteilung Pneumologie, Medizinischen Hochschule Hannover.
Klin Wochenschr. 1987 Oct 1;65(19):920-4. doi: 10.1007/BF01745503.
Lung function was studied double blind and randomized in 5 patients with mild asthma bronchiale and 10 normal adults before and 30, 60 and 90 minutes after one drop of 0.5% Timolol, 0.6% Metipranolol or 0.9% NaCl in each eye. In the asthmatics bronchoconstriction was seen after both beta-receptor blocking agents, more pronounced after Timolol than after Metipranolol. There was a decrease in the forced expiratory volume in one second (FEV1.0) of 32, respectively 18%. No changes were observed in the normal subjects. In a separate study no significant changes were seen in the mean values of 10 other asthmatic subjects after 1% Pindolol, 3% Pilocarpin or 0.9% NaCl. However, in two patients FEV1.0 was reduced by 15% and 20% of the control values after applying Pindolol. In summary, not only beta-receptor-blocking agents without ISA produce a bronchoconstriction in asthmatic subjects, but also beta-blocker with ISA in individual cases.
对5例轻度支气管哮喘患者和10名正常成年人进行了双盲随机研究,在每只眼睛滴入一滴0.5%噻吗洛尔、0.6%美替洛尔或0.9%氯化钠之前及之后30、60和90分钟测定肺功能。在哮喘患者中,两种β受体阻滞剂均可引起支气管收缩,噻吗洛尔引起的收缩比美替洛尔更明显。一秒用力呼气量(FEV1.0)分别下降了32%和18%。正常受试者未观察到变化。在另一项研究中,1%吲哚洛尔、3%毛果芸香碱或0.9%氯化钠应用于10名其他哮喘患者后,其平均值未出现显著变化。然而,两名患者在应用吲哚洛尔后,FEV1.0较对照值分别降低了15%和20%。总之,不仅无内在拟交感活性的β受体阻滞剂可在哮喘患者中引起支气管收缩,个别情况下有内在拟交感活性的β受体阻滞剂也可引起。